|
TELO Telomir Pharmaceuticals Inc 1971532 |
| Income Statement |
|
Net Income
|
form10-k
|
-16,532,716 |
| Balance Sheet |
|
Current Assets
|
1,324,005 |
|
Assets
|
1,324,005 |
|
Current Liabilities
|
680,968 |
|
Liabilities
|
680,968 |
|
Equity
|
643,037 |
|
Shares Out
|
29,610,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,070,428 |
| Market Analysis |
Market Cap
|
167,887,624 |
|
Price
|
4.27 |
|
BVPS
|
0.02 |
|
PB
|
199.54 |
|
EPS
|
-0.69 |
|
PS
|
0.32 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TELO documents filed with the SEC.
TELO Filings
Clear
